TrialThe Journal of antimicrobial chemotherapy2024

Use of the FebriDx® host-response point-of-care test may reduce antibiotic use for respiratory tract infections in primary care: a mixed-methods feasibility study.

Christopher R Wilcox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.